Skip to main content

Sepsis and Disseminated Intravascular Coagulation: Pathophysiological and Interventional Concepts

  • Conference paper

Abstract

Gram-negative septicaemia is a frequent complication following major surgery in high-risk patients and is a serious condition. Its mortality ranges from 40% to 60%, a rate which has remained unchanged in the past few decades, despite advances in general intensive medical care, modern antibiotic treatment, and new intervention modalities for the treatment of diffuse intravascular coagulation (DIC). This may be partly due to the increasing age of the general population and the increasing number of major surgical interventions in the elderly.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Van Deventer SJH, Büller HR, ten Cate JW, et al. (1990) Experimental endotoxaemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76: 2520–2526

    PubMed  Google Scholar 

  2. Suffredini AF, Harpel PC, Parillo JE (1989) Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. N Engl J Med 18: 1165–1171

    Article  Google Scholar 

  3. Taylor Jr FB, Esmon CT, Hinshaw LB (1991) Summary of staging mechanism and intervention studies in the baboon model of E. Coli sepsis. J Traumatol [Suppl] 12: 197–204

    Google Scholar 

  4. Taylor Jr FB, Chang A, Esmon CT, et al. (1988) Antithrombin-III prevents the lethal effects of Escherichia Coli infusions in baboons. Circ Shock 26: 227–235

    PubMed  CAS  Google Scholar 

  5. Taylor Jr FB, Chang A, Esmon CT, et al. (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia Coli infusion in the baboon. J Clin Invest 79: 918–925

    Article  PubMed  CAS  Google Scholar 

  6. Levi M, Hack CE,, de Boer JP et al. (1991) Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. J Clin Invest 88: 1155–1160

    Article  PubMed  CAS  Google Scholar 

  7. Van der Poll T, Büller HR, ten Cate H, et al. (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322: 1622–1626

    Article  PubMed  Google Scholar 

  8. Bauer KA, ten Cate H, Spriggs DR, et al. (1989) Tumor necrosis factor infusions have a procoagulant effect on hemostatic mechanism of humans. Blood 74: 165–172

    PubMed  CAS  Google Scholar 

  9. Blauhut B, Kramer H, Vinazzer H, Bergmann H (1985) Substitution of antithrom- bin-III in shock and DIC: a randomized study. Thromb Res 39: 81–89

    Article  PubMed  CAS  Google Scholar 

  10. Fourrier F, Chopin C, Huart JJ, Range I, Caron C, Goudemand J (1992) Double-blind, placebo-controlled trial of antithrombin-III concentrates in septic shock with disseminated intravascular coagulation [abstract]. Intensive Care Med 18: S50

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

ten Cate, J.W., van Beek, E.J.R. (1994). Sepsis and Disseminated Intravascular Coagulation: Pathophysiological and Interventional Concepts. In: Martin, E., Nawroth, P.P. (eds) Fachübergreifende Aspekte der Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93561-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93561-9_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58054-6

  • Online ISBN: 978-3-642-93561-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics